PTGS2 and rheumatoid arthritis: Since the inflammation in RA is related to COX-2 induced PGE2 production by synoviocytes and since S1P/S1P1 signaling may induce synovial hyperplasia and inflammation in RA, S1P/S1P1 signaling could be a therapeutic target in RA [657].